GlassScriptPhysician profile
Danko Martincic
NPI 1124071592
$1,117,253.62
in general payments reported to CMS, 2019-2025
78 companies · $190K in 2025
The $190K reported for 2025 was more than what 99% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144K · 2020: $91K · 2021: $176K · 2022: $218K · 2023: $155K · 2024: $142K · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $355K · Consulting Fee: $72K · Travel and Lodging: $38K · Food and Beverage: $18K · Honoraria: $3,750 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $355,158.92 |
| Consulting Fee | $71,735.09 |
| Travel and Lodging | $38,033.45 |
| Food and Beverage | $18,201.24 |
| Honoraria | $3,750.00 |
| Education | $259.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $418,619.68 | 2019-2025 | Reblozyl, Opdivo, Opdualag |
| Astrazeneca Pharmaceuticals LP | $230,709.06 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| Daiichi Sankyo INC. | $131,099.88 | 2019-2025 | Enhertu, Datroway |
| Seagen INC. | $64,910.78 | 2019-2025 | Adcetris, Padcev, Tukysa |
| Regeneron Healthcare Solutions, INC. | $44,180.36 | 2020-2025 | Libtayo, Lynozyfic |
| Pfizer INC. | $42,070.10 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $38,880.72 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $36,362.63 | 2019-2025 | Reblozyl, Opdualag |
| Genzyme Corporation | $32,054.83 | 2019-2025 | |
| Astellas Pharma US INC | $24,335.58 | 2022-2025 | Padcev, Xospata, Vyloy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13,579.41 | 2020-2025 | Gilotrif |
| Kite Pharma, INC. | $5,459.63 | 2022 | |
| Deciphera Pharmaceuticals INC. | $4,464.68 | 2021-2024 | Qinlock |
| Beigene USA, INC. | $4,209.46 | 2021-2025 | Brukinsa |
| Lilly USA, LLC | $4,092.49 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,409.27 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Janssen Biotech, INC. | $2,473.79 | 2019-2025 | Tecvayli, Darzalex, Carvykti |
| Abbvie INC. | $2,335.79 | 2020-2025 | |
| Gilead Sciences, INC. | $2,259.00 | 2019-2025 | Trodelvy |
| Astellas Pharma Global Development | $2,010.26 | 2021-2024 | Padcev |
| Servier Pharmaceuticals LLC | $1,896.20 | 2022-2025 | |
| Morphosys, US INC. | $1,194.58 | 2022-2024 | Monjuvi |
| Exelixis INC. | $1,143.41 | 2019-2025 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $734.05 | 2019-2025 | |
| Genentech USA, INC. | $397.54 | 2019-2025 | Tecentriq, Alecensa, Perjeta |
| Eisai INC. | $294.61 | 2022-2025 | |
| Amgen INC. | $282.62 | 2019-2023 | Nplate, Xgeva, Vectibix |
| Bayer Healthcare Pharmaceuticals INC. | $223.33 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $213.23 | 2022-2023 | Fotivda |
| Dendreon Pharmaceuticals LLC | $212.13 | 2021-2025 | Provenge |
| Legend Biotech USA INC. | $182.59 | 2024-2025 | Carvykti |
| Adc Therapeutics America, INC. | $178.07 | 2023-2024 | |
| Ipsen Biopharmaceuticals, INC | $163.24 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Galvanize Therapeutics, INC | $145.00 | 2023 | Aliya System |
| Array Biopharma INC | $138.88 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Foundation Medicine, INC. | $134.00 | 2019-2023 | |
| Karyopharm Therapeutics INC. | $129.46 | 2020-2023 | Xpovio |
| Telix Pharmaceuticals | $125.00 | 2024 | Illuccix |
| Shire North American Group INC | $124.68 | 2019 | |
| Blueprint Medicines Corporation | $123.91 | 2021-2024 | Ayvakit |
| Myriad Genetic Laboratories, INC. | $110.55 | 2021-2023 | Myrisk, Precisetumor |
| Puma Biotechnology, INC. | $110.44 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $100.51 | 2022-2025 | |
| Novocure INC. | $90.17 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $83.98 | 2019-2023 | Imbruvica |
| Pharmacosmos Therapeutics INC. | $81.73 | 2023-2025 | Monoferric |
| Acrotech Biopharma INC. | $79.75 | 2023-2025 | Beleodaq |
| Rigel Pharmaceuticals, INC. | $76.82 | 2020-2024 | Tavalisse, Rezlidhia |
| Stemline Therapeutics INC. | $73.78 | 2023-2024 | Elzonris |
| Ascendis Pharma Endocrinology INC | $71.52 | 2025 | Yorvipath |
| Mirati Therapeutics, INC. | $59.42 | 2023-2024 | Krazati |
| Adaptive Biotechnologies Corporation | $58.35 | 2023-2024 | Clonoseq |
| Emd Serono, INC. | $56.50 | 2023-2024 | Bavencio |
| Takeda Pharmaceuticals U.S.A., INC. | $55.41 | 2022-2025 | Alunbrig |
| Sumitomo Pharma America, INC. | $45.85 | 2024-2025 | Orgovyx |
| Incyte Corporation | $45.02 | 2024 | Jakafi |
| Kedrion Biopharma, INC. | $43.66 | 2024 | Gammaked, Kedrab, Koate |
| Sobi, INC | $41.51 | 2024 | |
| Sanofi-Aventis U.S. LLC | $40.26 | 2020 | |
| Epizyme, INC. | $40.13 | 2020 | |
| Progenics Pharmaceuticals, INC. | $39.72 | 2023 | Pylarify |
| Janssen Scientific Affairs, LLC | $37.84 | 2023 | Tecvayli, Darzalex |
| Myovant Sciences INC. | $31.58 | 2021-2022 | |
| Menarini Silicon Biosystems, INC. | $25.54 | 2023 | Cellsearch |
| Sun Pharmaceutical Industries INC. | $24.97 | 2024 | |
| Fennec Pharmaceuticals, INC. | $24.36 | 2025 | Fyarro |
| Springworks Therapeutics, INC. | $22.04 | 2024 | Ogsiveo |
| Delcath Systems | $21.55 | 2025 | Hepzato Kit |
| Genmab U.S., INC. | $20.83 | 2024 | Epkinly |
| Eusa Pharma (US) LLC | $19.46 | 2022 | |
| Beone Medicines USA, INC. | $19.33 | 2025 | Brukinsa |
| Heron Therapeutics, INC. | $17.43 | 2021 | |
| Alnylam Pharmaceuticals INC. | $15.81 | 2023 | Givlaari |
| Spectrum Pharmaceuticals INC. | $13.87 | 2024 | Rolvedon |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danko Martincic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.